top of page
Strengthen already existing vaccine technologies
with an exclusivity IP on targeted application
Co-development of new vaccines
for emerging applications on specific species
We provide preclinical and clinical services to potentialize your vaccines with CyaA (AC-) technology and unique companion animal immunomonitoring platform
We propose to co-develop new vaccines for unmet needs untill the commercial authorization
bottom of page